Coexistence of Dual Chromosomal Abnormalities t(3;7) and t(9;22) in Case of B-Acute Lymphoblastic Leukemia: a Rare Genomic Profile with Diagnostic and Prognostic Challenges.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
환자: B-ALL confirmed through biopsy and immunophenotyping
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
Translocation t(3;7) is rarely observed and is associated with a worse/ poor prognosis. Hence, the identification of such translocations in patients with B-ALL can aid in patient stratification, personalized medicine, and risk assessment.
Acute lymphocytic leukemia (ALL) is a hematologic malignancy marked by clonal growth of lymphoid precursors within the bone marrow, resulting in disrupted hematopoiesis.
APA
Trivedi PJ, Patel N, et al. (2026). Coexistence of Dual Chromosomal Abnormalities t(3;7) and t(9;22) in Case of B-Acute Lymphoblastic Leukemia: a Rare Genomic Profile with Diagnostic and Prognostic Challenges.. Journal of the Association of Genetic Technologists, 52(1), 17-21.
MLA
Trivedi PJ, et al.. "Coexistence of Dual Chromosomal Abnormalities t(3;7) and t(9;22) in Case of B-Acute Lymphoblastic Leukemia: a Rare Genomic Profile with Diagnostic and Prognostic Challenges.." Journal of the Association of Genetic Technologists, vol. 52, no. 1, 2026, pp. 17-21.
PMID
41764641 ↗
Abstract 한글 요약
Acute lymphocytic leukemia (ALL) is a hematologic malignancy marked by clonal growth of lymphoid precursors within the bone marrow, resulting in disrupted hematopoiesis. Chromosomal abnormalities provide valuable information on the development of ALL and serve as a key indicator of patient outcomes and treatment strategies. Numerous genetic abnormalities can be seen in ALL. Here, we described a case of a 15-year-old patient with B-ALL confirmed through biopsy and immunophenotyping. Conventional cytogenetic and FISH analysis showed t(3;7) with the presence of t(9;22). Translocation t(3;7) is rarely observed and is associated with a worse/ poor prognosis. Hence, the identification of such translocations in patients with B-ALL can aid in patient stratification, personalized medicine, and risk assessment.